Recent Company News

• 03:33 AM ET Sep 22, 2025
  

  SCHOTT Pharma re-initiated outperform at BNP Paribas Exane (pre-open) (€21.90, +0.25)

• 01:08 AM ET Aug 12, 2025
  

  SCHOTT Pharma reports Q3 EPS €0.30 vs FactSet €0.30 [5 est, €0.26-0.33] (€24.35, 0.00)

• 03:57 AM ET Aug 05, 2025
  

  SCHOTT Pharma specifies FY25 guidance (€24.05, +0.05)

• 02:58 AM ET Jun 11, 2025
  

  SCHOTT Pharma appoints Reinhard Mayer as new CFO; CEO Andreas Reisse contract extended (€29.55, 0.00)

• 02:47 AM ET Apr 11, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:06 AM ET May 20, 2025
  

  SCHOTT Pharma upgraded to overweight from equal weight at Barclays (€27.05, 0.00)

• 01:16 AM ET May 15, 2025
  

  SCHOTT Pharma reports Q2 EPS €0.26 vs FactSet €0.24 [3 est, €0.22-0.28]; reaffirms FY25 guidance (€26.00, 0.00)

• 01:23 AM ET May 06, 2025
  

  TPG has entered into binding agreement to acquire 35% stake in JV SCHOTT Poonawalla from Serum Institute of India; terms undisclosed (€25.30, 0.00)

• 12:42 PM ET Apr 10, 2025
  

  SCHOTT Pharma announces preliminary Q2 EBITDA €72M vs FactSet €60.4M (€19.88, 0.00)